JAAD International (Jun 2022)
Psoriasis adverse events and associated medications as reported in the US Food and Drug Administration’s Adverse Event Reporting System from 2016 to 2021
- Christine Learned, BA,
- Sara Alsukait, MBBS,
- Sandhya Deverapalli, MD, MBBS,
- Erika Elliott, MD,
- Katherine Moody, MD,
- Jeffrey Sobell, MD,
- Nellie Konnikov, MD,
- Melissa Ortega, PharmD,
- David Rosmarin, MD
Affiliations
- Christine Learned, BA
- Department of Dermatology, Tufts Medical Center, Boston, Massachusetts
- Sara Alsukait, MBBS
- Department of Dermatology, Tufts Medical Center, Boston, Massachusetts
- Sandhya Deverapalli, MD, MBBS
- Department of Dermatology, Tufts Medical Center, Boston, Massachusetts
- Erika Elliott, MD
- Department of Dermatology, Tufts Medical Center, Boston, Massachusetts
- Katherine Moody, MD
- Department of Dermatology, Tufts Medical Center, Boston, Massachusetts
- Jeffrey Sobell, MD
- Department of Dermatology, Tufts Medical Center, Boston, Massachusetts
- Nellie Konnikov, MD
- Department of Dermatology, Boston VA Medical Center, Boston, Massachusetts
- Melissa Ortega, PharmD
- Department of Pharmacy, Tufts Medical Center, Boston, Massachusetts
- David Rosmarin, MD
- Department of Dermatology, Tufts Medical Center, Boston, Massachusetts; Correspondence to: David Rosmarin, MD, Department of Dermatology, Tufts Medical Center, 800 Washington Street, Boston, MA 02111
- Journal volume & issue
-
Vol. 7
pp. 144 – 145